shift image

Shift is Happening Now

By Daniel R. Matlis, President

What Can Pharma CIOs do to Enable Innovation

What is the role of a CIO in a Pharma / Life-Science company?  Traditionally, the role of the CIO has been to manage the IT portfolio, implement systems, manage infrastructure and control IT costs to support the business.

With the unprecedented rate of shift the industry is experiencing, CIO’s can no longer simply be tasked with managing portfolios and budgets.

This was evident at the 2015 CIO Innovation Summit in Kyoto, Japan on October 20th.

There, Executives from leading organizations across the Life-Sciences ecosystem in Asia converged at the Ritz Carlton in Kyoto to learn about industry trends and share success stories and current best practices (cBPs).

Key themes at the event included innovation, transformation, collaboration and connectivity.  The event was hosted by BIOVIA – Dassault Systemes and brought together top executives from:

  • Astellas Pharma
  • Bridgestone
  • Bionet
  • Daichi Sankyo Biovia
  • Everlight Chemical
  • Genesis Genetics Asia
  • IPCA Laboratories
  • Samsung Biologics
  • Shionogi &Co
  • Sumitomo Danippon
  • Takeda Pharmaceuticals
  • Mitsui Chemicals
  • WuXi Apptech

Max Carnecchia, BIOVIA’s CEO, set the tone for the event in his opening remarks. His message: “By transforming the pharmaceutical industry through innovation, collaboration and connectivity, we can streamline end-to-end manufacturing, enhance quality and improve compliance in today’s challenging regulatory and risk environment.”

To learn more about illuminating dark data, please click here for a PDF copy of the entire Event Brief.

Stopwatch - shutterstock_99873074

NEW SURVEY: The Future of Change and Configuration Management

Your Input to Med-Tech Survey Donates to Children’s Miracle Network Hospitals®

Axendia is conducting a research study to identify change and configuration management trends in the Medical Device Industry.

Medical devices are in a constant state of evolution: providing new capabilities, addressing defects, adapting to changing markets or regulatory demands and reacting to competitive threats.

To access the survey, please click here.

Continue reading

webinar pic

Beyond Compliance – Accelerating Medical Device Innovation

Webinar Announcement

Accelerating medical device innovation in the midst of increasing regulations and global expansion requires new business strategies.

Join analyst and strategic advisory firm Axendia President Daniel R. Matlis and a panel of industry experts, including Dave Hadfield of Kalypso, for an insightful discussion on global innovation and quality challenges faced by our industry.

Title: “Beyond Compliance – Accelerating Medical Device Innovation” presented by Dassault Systèmes and SmartBrief

Date: Thursday, October 29, 2015

Time: 2:00 PM Eastern Daylight Time

This one-hour webinar will explore:

  • FDA’s shift from compliance to quality
  • Challenges and opportunities in today’s global and outsourced environment
  • Designing, sourcing, manufacturing and marketing in a global marketplace
  • Personalized and customized device development
  • Device traceability and managing UDI proactively
  • Managing the total product lifecycle
  • Designing for manufacturability and building quality by design


  • Daniel R. Matlis, President, Axendia
  • Arieh Halpern, Life Sciences Industry Business Consultant Director, Dassault Systèmes
  • Dave Hadfield, Senior Manager, Kalypso

Registration Link.


Siemens Industry Analyst Conference 2015

By Sandra K. Rodriguez, Research Associate

Digital Twins Enable Time Travel

If you had a time machine, would you rather take a peek in to the future or change something in the past?   If you could build a digital twin that enabled time travel, would you?

The theme of this year’s Siemens Industry Analyst Conference was Realizing Innovation.   Virtualization and digitalization capabilities throughout the product lifecycle are giving industry the opportunity to do something new – time travel.

Continue reading


Earning Your Trust for Ten Years

By Daniel R. Matlis, President

Axendia Turns Ten!

Ten years ago, Axendia was founded on the premise to provide trusted advice to Life Science and Healthcare Industry Executives on Business, Technology and Regulatory matters.

Over the last ten years, we have had the privilege to earn the trust of executives across Life Science and Healthcare ecosystems.  As a result, we have advised industry, technology & service providers, policy makers and regulators.

We are committed to building, nurturing and growing long term relationships based on our core values: Respect, Integrity and Passion.

This commitment to our clients, partners and team members has fostered a spirit of cooperation, coordination and trust that is essential to ensuring success.

How do we measure success?

Our success is based on yours.  We measure success based on the contributions we have made to you and your organization as well as the commitment to our mission: “to be trusted advisors to Industry Executives.”

During the last ten years:

  • We have had the privilege of advising Life-Science, Healthcare and Food companies ranging from startups to Fortune 100 companies.
  • We have had the opportunity to work with leading technology and service providers.
  • We have published numerous primary research studies, whitepapers, articles and infographics.
  • We have been invited to present at leading industry conferences and at the FDA.
  • We have conducted briefings for audiences around the globe, including Asia, Europe, North and South America
  • We began writing a blog in 2006, before blogging was cool. Today, we have thousands of subscribers to Life-Science Panorama, and you can also follow us on Twitter and LinkedIn.

I hope that over the past ten years we have earned your trust and that Axendia hastrust become a source of trusted advice for you.

Thank you for your support and we look forward to continuing to build long-term relationships based on our core values: Respect, Integrity and Passion.